Search
for
Sort by
Research 541–570 of 1000+
- Aseptic Necrosis of Warts Instead of Lymphangitis
- Alopecia areata
- Pathobiology of chemotherapy-induced hair loss
- Telogen Effluvium
- Molecular biology of hair morphogenesis: Development and cycling
- Hormonal Therapy for Acne
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Dermatoscopy of hair shaft disorders
- The role of lymphocytes in the development and treatment of alopecia areata
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Hair: What is New in Diagnosis and Management?
- Endocrine-skin interactions
- Endocrinologic Aspects of Hidradenitis Suppurativa
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- Tuning Wnt Signals for More or Fewer Hairs
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis
- MOUSE MODELS FOR THE STUDY OF HUMAN HAIR LOSS
- Prognosis and Management of Congenital Hair Shaft Disorders with Fragility—Part I
- Understanding and Management of Female Pattern Alopecia
- Macrophage-Stimulating Protein Promotes Hair Growth Ex Vivo and Induces Anagen from Telogen Stage Hair Follicles In Vivo
- LOOSE ANAGEN SYNDROME AND LOOSE ANAGEN HAIR
- Hair Loss in Systemic Disease
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Optimized polycystic ovarian disease prognosis and classification using AI based computational approaches on multi-modality data
- What′s new in cicatricial alopecia?
- Therapeutic options in the polycystic ovary syndrome
- What Ages Hair?